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The Argi system: one-step 
purification of proteins tagged 
with arginine-rich cell-penetrating 
peptides
Filip Bartnicki1, Piotr Bonarek2, Ewa Kowalska1 & Wojciech Strzalka1
The discovery of cell penetrating peptides (CPPs) opened new perspectives for the delivery of proteins 
into human cells. It is considered that in the future CPP-mediated transport of therapeutic proteins may 
find applications in the treatment of human diseases. Despite this fact a fast and simple method for the 
purification of CPP-tagged proteins, free of additional tags, was not available to date. To fill this gap we 
developed the Argi system for one-step purification of proteins tagged with arginine rich CPPs.
Cell penetrating peptides (CPPs) are short peptides capable of traversing the plasma membrane. Therefore, they 
can promote the transport of low and high molecular weight cargos, including peptides and proteins, into the 
cell1. Based on their biochemical properties CPPs are classified into three groups: (i) cationic, (ii) amphipathic 
and (iii) hydrophobic2. Among cationic CPPs a subgroup of arginine rich peptides which can be subdivided into: 
(i) poly-arginine peptides3, 4, (ii) Tat peptides3 and (iii) (R-Ahx-R)4 peptides5, can be distinguished. Poly-arginine 
CPPs include for example R6, or R8 peptides composed of six or eight consecutive arginine residues, respectively4. 
One of the Tat peptide variants called Tat49–57, which originates from the human immunodeficiency virus (HIV) 
Tat protein, is composed of nine amino acids including six arginine residues6. Finally, the synthetic (R-Ahx-R)4 
peptide has eight arginine residues which are interspersed with 6-aminohexanoic acid spacers5.
Recently, particular attention has been given to studies of potential therapeutic application of CPPs. It is con-
sidered that in the future they could play the role of transporters for externally delivered therapeutics, which must 
cross the plasma membrane to provide the proper functioning of the organism. The advantage of cellular cargo 
delivery using CPPs is that a broad range of different cell types can uptake these peptides3. In vitro studies on 
cationic CPP cytotoxicity showed that they can be tolerated by cells at much higher concentrations than amphip-
athic CPPs. Although CPP-based therapy has not yet entered human, but only in vitro and animal clinical trials, 
the current results may be cautiously considered as optimistic7. There are numerous reports where successful 
transport of various cargos into different types of cells including plant cells using arginine-rich peptides, was 
demonstrated8–14.
One of the obstacles that limits the potential therapeutic use of arginine-rich CPP-tagged proteins is the lack 
of appropriate tools dedicated for their purification. For example, up till now CPP-tagged proteins could be puri-
fied using multistep conventional chromatography methods, which is laborious, time consuming and may yield a 
product of unsatisfactory quality and quantity. Alternatively, to provide simple and fast purification of these pro-
teins by affinity chromatography additional tags, e.g. His-tag can be fused with CPP-tagged proteins8. However, 
the additional tag may have a negative impact on the CPP-tagged protein activity. Moreover, in the case of thera-
peutic applications of the protein the possible induction of human immune response by the additional tag cannot 
be ignored. For the above reasons the unnecessary extra tag should be removed, which is not always possible, and 
separated from the protein which significantly increases the cost of large scale CPP-tagged protein production.
The lack of an affinity chromatography system that could be used for efficient purification of arginine rich 
CPP-tagged proteins is mainly due to the fact that a natural ligand characterized by specific and easily reversi-
ble binding of such CPPs was not identified. Therefore, to overcome the current problems with the methodol-
ogy of arginine-rich CPP-tagged protein purification, minimize the risk of a possible immune response against 
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CPP-tagged therapeutics and to reduce the costs of CPP-tagged protein production in the future, we present 
here the development of the Argi system – a new affinity chromatography tool for one-step purification of 
arginine-rich CPP-tagged proteins. The presented system is based on the interaction between a DNA aptamer 
and arginine-rich CPPs.
Results
Selection of an arginine-rich CPP-binding aptamer. To create the Argi system we employed system-
atic evolution of ligands by exponential enrichment (SELEX15, 16). A DNA aptamer characterized by specific and 
reversible binding to poly-arginine and the Tat49–57 peptide, fused either to the N- or C- terminus of the tested 
protein, under mild buffer conditions, was identified. The selection strategy was similar to the one we employed 
previously17. We used a peptide containing eight consecutive arginines (H6G4R8) as a selection target during the 
first and second round of SELEX. Next, from the third to the eighth selection round R8-PCNA was used as a 
target. The progress of selection was evaluated using qPCR with R8-PCNA as a target (Fig. 1). The aptamer pool 
after the eighth selection round was cloned and sequenced. Among the 50 analyzed clones we found 12 different 
aptamer sequences. Next, using again qPCR the binding of single aptamers to R8-GST was evaluated and com-
pared. The highest value of the enrichment parameter was observed for the aptamer sequence number 2 called 
24–10 (Fig. 2) which was selected for further studies. The specificity of this molecule was verified and confirmed 
(Fig. 3).
To test whether the 24–10 aptamer can be used to capture proteins tagged with either the R6-tag, R8-tag or 
Tat49–57-tag we analyzed and compared the binding of the following proteins, GFP, GFP-R6, GFP-R8, GFP-Tat49–57, 
GST, R6-GST, R8-GST, Tat49–57-GST, PCNA, R6-PCNA, R8-PCNA and Tat49–57-PCNA, to the 24–10 or reference 
Figure 1. qPCR analysis of aptamer pool binding to R8-PCNA. The enrichment of aptamer pools (selection 
rounds 1–8) was expressed as the ratio: binding of tested aptamer pool/binding of initial ssDNA library to R8-
PCNA. Results are the mean of three measurements. Error bars represent the standard deviation.
Figure 2. qPCR analysis of selected aptamer binding to R8-GST. The enrichment of single aptamers was 
expressed as the ratio: binding of tested aptamer/binding of reference aptamer to R8-GST. Results are the mean 
of three measurements. Error bars represent the standard deviation.
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aptamer immobilized to streptavidin-agarose resin (High Capacity Streptavidin-agarose, HCSA). In line with our 
expectations, this experiment showed that R6-, R8- and Tat49–57-tagged proteins could be successfully captured 
only when the 24–10 aptamer was used (Fig. 4, Supplementary Fig. 1).
Identification of the 24–10 aptamer region necessary for arginine-rich CPP binding. To deter-
mine the region of the 24–10 aptamer crucial for binding of the studied arginine-rich CPP tags, R8-GST was used 
as a model. With the help of the pull-down assay the binding of R8-GST to variants of the 24–10 aptamer short-
ened from either the 5′ or 3′ end, as well as the full length aptamer, was evaluated based on densitometric analysis 
(Fig. 5A,B). This experiment showed that the sequence from nucleotides 31 to 70, referred to as the AR aptamer 
(5'-CTTTGTAATTGGTTCTGAGTTCCGTTGTGGGAGGAACATG-3'), could bind the R8-tag the most effi-
ciently. The modeling of the AR aptamer with mfold18 software predicted the formation of four possible structures 
(Fig. 6). The calculated folding ΔG for structures A, B, C and D was −10.34, −9.86, −9.76 and −9.43 kcal/mol, 
respectively.
Analysis of elution conditions for arginine-rich CPP-tagged proteins. Among the key features 
which should characterize affinity chromatography systems, used for recombinant protein purification, the 
efficient binding of the analyte and its simple elution under mild buffer conditions should be considered. The 
demonstrated specific interaction between the AR aptamer and tested arginine-rich tags, although crucial, was 
insufficient to fully assess the possible application of the developed ssDNA for chromatography purposes. This is 
why in the following experiment the conditions of analyte elution from the AR aptamer were analyzed. Testing 
buffers supplemented with increasing amounts of guanidine hydrochloride (GuHCl) we showed that to elute 
more than 90% of R6-, R8- and Tat49–57-GST bound to the AR aptamer, 500, 600 and 200 mM GuHCl, respectively 
was necessary (Fig. 7A–C). Despite the fact that GuHCl is widely used as a protein denaturant it is well known 
that at mM concentrations it is usually not harmful but can stabilize proteins19.
Determining the dissociation constant of AR aptamer/arginine-rich CPP complexes. To 
evaluate the affinity between the developed ssDNA and the studied tags the dissociation constant (Kd) of AR 
aptamer/arginine-rich tag complexes was determined. The Kd, determined using isothermal titration calorim-
etry, for the AR aptamer and R6-GST, R8-GST and Tat49–57-GST was 943 ± 37 × 10−9 M, 532 ± 55 × 10−9 M and 
893 ± 44 × 10−9 M (Fig. 8), respectively. All reactions were exothermic and enthalpy-entropy driven (Table 1). The 
analysis of stoichiometry revealed that one molecule of AR-aptamer can bind two molecules of the tested tags.
Evaluation of AR aptamer application for purification of CPP-tagged proteins. Finally, when the 
biochemical studies of the Argi system were completed, to test the developed tool in real conditions the purifica-
tion of nine different protein variants (GFP-R6, GFP-R8, GFP-Tat49–57, R6-GST, R8-GST, Tat49–57-GST, R6-PCNA, 
R8-PCNA and Tat49–57-PCNA) from E. coli total protein extract was performed and analyzed. These experiments 
clearly confirmed the applicability of the developed AR aptamer for the purification of recombinant proteins 
tagged with arginine-rich peptides (Fig. 9). Moreover, we found that using 175 μg of AR aptamer we could purify 
from 145 to 594 μg of protein (Supplementary Table 1). Additionally, analyzing the reproducibility of the Argi 
system we found that during nine purification cycles the quality of isolated proteins was not significantly affected 
(Fig. 10).
Discussion
In this study we presented the development of the Argi system which is a powerful tool for one-step purifica-
tion of recombinant proteins tagged with arginine-rich cell-penetrating peptides overexpressed in E. coli cells. 
Besides the application of poly-arginine peptides for cargo transport, in 1984 the utilization of this tag for the 
purification of recombinant proteins was proposed20, but has not found a wide application in laboratories. The 
Figure 3. Analysis of 24–10 aptamer specificity using qPCR. The enrichment was expressed as the ratio: 
binding of tested aptamer/binding of reference aptamer to GST or R8-GST. Results are the mean of three 
measurements. Error bars represent the standard deviation.
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purification of arginine-rich peptide-tagged proteins was based on the use of non-specific ion exchange chro-
matography. However, the pH of the buffers used during purification was far from the pH range which is usually 
optimal for protein stability and activity. The applied buffer conditions could possibly be harmful for the biolog-
ical activity of many proteins. On the other hand other studies demonstrated that the poly-arginine tag could 
improve protein solubility21. Despite previous reports, an affinity chromatography system for the purification of 
poly-arginine-tagged proteins was never developed. Therefore, the presented new chromatography tool offers a 
much easier method of arginine rich CPP-tagged protein purification, which was not available up to date.
Figure 4. Analysis of the 24–10 aptamer specificity. 5′-biotinylated reference (Ref) (lanes 1–4) or 24–10 (lanes 
5–8) aptamer immobilized to streptavidin-agarose resin was incubated with appropriate variants of (A) GFP, 
(B) GST and (C) PCNA proteins. Protein without tag (lanes 1, 5), protein with R6 tag (lanes 2, 6), protein with 
R8 tag (lanes 3, 7), protein with Tat49–57 tag (lanes 4, 8). After washing, the protein sample was denatured and half 
of the protein sample volume of the bound protein was separated on 12% SDS-PAGE gel followed by Coomassie 
brilliant blue staining. This is one of three independent experiments which is representative.
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Materials and Methods
Experimental. Chemicals and plasmids. The chemicals used in this work were obtained from Sigma-
Aldrich (USA) and Merck (Germany) unless indicated otherwise. Synthetic aptamers, the ssDNA library 
and reference aptamer (5′-CATGCTTCCCCAGGGAGATGACTGACTGACTGACTGACTGACTGACT 
GACTGACTGACTGGAGGAACATGCGTCGCAAAC-3′) were obtained from IBA GmbH (Germany). The 
template plasmids pDNR-LIB (coding for human PCNA), pGEX4T-1 (coding for GST) and pK7WGF2 (coding 
for GFP) were purchased from ImaGenes GmbH, GE HealthCare and VIB Department of Plant Systems Biology, 
University of Ghent, respectively.
Protein immobilization. The H6G4R8 peptide (LifeTein, USA) was dissolved in DMSO to a concentration of 
1 mg/mL. Next, 10 μg of the peptide was mixed with 0.5 μL 50% cobalt-coated agarose beads (TALON, Clontech) 
and the mixture was incubated in AS1 buffer (136 mM NaCl, 12 mM KCl, 10 mM Na2HPO4, 1.7 mM KH2PO4, 
4.9 mM MgCl2, 0.01% (v/v) Tween 20; pH 7.5) for 1 h at RT with continuous mixing. To remove the unbound 
peptide, after immobilization the beads were washed 3x with AS1 buffer. Immobilization of R8-GST, GST or 
Figure 5. Identification of the 24–10 aptamer region optimal for R8 binding. The binding of R8-GST to the 
full length 24–10 aptamer, as well as its variants appropriately shortened from the 5′ or 3′ end, was tested. (A) 
Pull down assay. Lanes: (1) full length 24–10, (2) 24–10 (5′/−10), (3) 24–10 (3′/−10), (4) 24–10 (5′/−10 and 
3′/−10), (5) 24–10 (5′/−10 and 3′/−20), (6) 24–10 (5′/−20 and 3′/−10), (7) 24–10 (5′/−30 and 3′/−10) and 
(8) 24–10 (5′/−40 and 3′/−10) aptamer variants immobilized on streptavidin agarose beads were incubated 
with the analyzed protein. The bound protein was denatured. Next, one fortieth of the volume of each protein 
sample was separated on 12% SDS-PAGE followed by Coomassie staining. This is one of three independent 
experiments which is representative. (B) Densitometric analysis of data from three independent pull down 
assays was done using Multispectral Imaging System IMAGER with Launch VisionWorksLS. Results are the 
mean of three measurements. The error bars represent standard deviation. The results were normalized relative 
to signal from the protein sample bound by the full length aptamer (100%).
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R8-PCNA to CNBr-activated Sepharose 4B (Pharmacia) was performed according to the protocol supplied by 
the manufacturer.
Cloning and plasmid construction. Nucleotide sequences coding for GFP-R6/R8/Tat49–57, R8/Tat49–57-GST and 
R8/Tat49–57-PCNA were amplified using sets of specific primers (Supplementary Table 2) and cloned into the 
pET29a vector as described previously17 with minor modifications. The following PCR conditions were used: 
preliminary denaturation at 94 °C for 2 min, 30 cycles of amplification (94 °C for 40 s, 58 °C for 30 s, 72 °C for 
3 min), final incubation at 72 °C for 7 min. The PCR products were purified, digested with BamHI and NdeI 
(FastDigest, Thermo Scientific) restriction enzymes and cloned into the pET29a expression vector using T4 DNA 
Figure 6. AR aptamer putative secondary structure analysis. The (A–D) structures were modeled using mfold 
web server.
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ligase (Thermo Scientific), followed by sequencing. The construction of E. coli expression vectors carrying PCNA- 
and GFP-coding sequences was previously described17. Open reading frames coding for R6-GST and R6-PCNA 
were synthetized by Genscript.
Protein overexpression. The GFP, GFP-R6/R8/ Tat49–57, GST, R6/R8/ Tat49–57-GST, PCNA, and R6/R8/ Tat49–
57-PCNA proteins were overexpressed as described previously for GFP, GST and PCNA17.
Protein purification. All the purification steps were performed at 4 °C similarly as described previously17. The E. 
coli cells containing all variants of GFP, GST and PCNA were resuspended in GFP buffer (50 mM Tris-HCl, 3 M 
NaCl, pH 8.0), PBS(140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,1.8 mM KH2PO4, pH 7.3) buffer and PCNA 
buffer (50 mM Tris-HCl, pH 7.6), respectively. Phenylmethylsulfonyl fluoride (PMSF) was then added to 1 mM 
Figure 7. Determination of optimal GuHCl concentration for analyte elution. 5′-biotinylated AR aptamer 
bound to streptavidin agarose resin was incubated with GST fused with the indicated tag. After washing, the 
bound protein was eluted using Tris-HCl buffer supplemented with the appropriate GuHCl concentration. 
Next, the protein samples were denatured and one fortieth of the volume of each sample was separated on 12% 
SDS-PAGE followed by Coomassie staining and analyzed using Multispectral Imaging System IMAGER with 
Launch VisionWorksLS. The results were normalized relative to signal from the protein sample eluted with 
buffer supplemented with 0 mM GuHCl (0% eluted protein). Recombinant GST protein tagged with: (A) R6, (B) 
R8 and (C) Tat49–57 peptide. Each panel presents the results of one of three independent experiments which is 
representative.
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final concentration. Next, the samples were sonicated (10 min, 5 s pulses, 10 s break) and centrifuged (30,000x g 
for 30 min) to obtain E. coli total protein extracts. Next, the proteins were purified as described below. At the final 
step of protein purification the fractions containing the protein of interest were pooled, dialyzed against a S buffer 
(50 mM Tris-HCl, 150 mM NaCl, 15% (v/v) glycerol, pH 7.5), frozen in liquid nitrogen and stored at −80 °C until 
use.
GFP and GFP-R6/R8/ Tat49–57 purification. The protein extract was loaded onto a 5 mL HiTrap Butyl HP column 
(GE Healthcare) equilibrated with GFP buffer. The unbound proteins were washed out with GFP buffer. Next, the 
bound proteins were eluted using 200 mL of linear gradient from 3–0 M NaCl. To obtain the satisfactory protein 
purity, the fractions containing the protein of interest were dialysed against PCNA buffer and loaded onto a 5 mL 
High Q (Bio-Rad) column. After washing with PCNA buffer the bound proteins were eluted using 200 mL of 
linear gradient from 0–0.8 M NaCl in PCNA buffer.
GST and R6/R8/ Tat49–57-GST purification. The protein extract was loaded onto a 2 mL Glutathione Sepharose 4B 
column (GE Healthcare) equilibrated with PBS buffer. The unbound proteins were washed out with PBS buffer. 
Next, the bound protein was eluted with GST elution buffer (50 mM Tris-HCl, 50 mM reduced glutathione, pH 
8.0).
PCNA and R6/R8/ Tat49–57-PCNA purification. The proteins were purified according to the protocol described 
previously for PCNA and His3-PCNA17.
SELEX procedure. The SELEX procedure was performed as described previously17 with some modifications. 
AS1 buffer was used for aptamer selection. The H6G4R8 peptide bound to TALON cobalt-coated agarose beads 
(Clontech), which were shown previously to provide good selection power22, was used for selection rounds I and 
II. For selection cycles III to VIII R8-PCNA, immobilized to to CNBr-activated Sepharose 4B (Pharmacia), was 
used as a target molecule.
Quantitative real-time PCR. qPCR analysis of aptamer binding, enrichment and specificity was per-
formed as described previously17. R8-PCNA was used as a target when the enrichment parameter was analyzed 
for the aptamer pool after each SELEX cycle. R8-GST was used to test the enrichment of particular aptamer 
sequences. R8-GST and GST were used to evaluate the specificity of the 24–10 aptamer.
Figure 8. Determination of the AR aptamer/arginine-rich peptide complex dissociation constants. Integrated 
heats of binding corrected for heats of dilution from titrations of R8-GST (squares), R6-GST (circles) and 
Tat49–57-GST (triangles) into the solution of AR aptamer at 25 °C. Experiments were performed in 50 mM 
phosphate buffer (pH 7.6) containing 207 mM NaCl. Solid lines represent the best-fit binding isotherms to the 
experimental data.
Stoichiometry ΔG (kJ/mol) ΔH (kJ/mol) ΔS (J/mol K)
R6-GST 2.61 ± 0.03 −35.8 ± 0.3 −27.7 ± 0.3 27.2 ± 1.9
R8-GST 2.51 ± 0.02 −34.4 ± 0.1 −31.0 ± 0.2 11.4 ± 0.8
Tat49–57-GST 2.08 ± 0.02 −34.5 ± 0.2 −31.9 ± 0.2 8.9 ± 1.1
Table 1. Thermodynamic parameters of AR aptamer interaction with R6-GST, R8-GST and Tat49–57-GST 
determined according to the one set of sites model with assumption that the ligand is in the measurement cell.
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Pull-down-based assays. Assays were performed at 4 °C using a universal spin column (MoBiTec) and 
High Capacity Streptavidin Agarose (HCSA) resin (ThermoScientific). After each washing or elution step, the 
resin was incubated for 5 min before centrifugation (800xg for 30 s).
Figure 9. Analysis of arginine-rich peptide-tagged protein purification from E. coli total protein extract using 
AR aptamer-based chromatography. The recombinant proteins: GFP-R6 (A), R6-GST (B), R6-PCNA (C), GFP-R8 
(D), R8-GST (E), R8-PCNA (F), GFP-Tat49–57 (G), Tat49–57-GST (H) and Tat49–57-PCNA (I) were overexpressed 
and purified from E. coli total protein extract using AR aptamer. Lanes: M) molecular weight marker; 1) non-
induced BL21-CodonPlus(DE3)-RIL[pET29a arginine-rich peptide-tagged protein] cells; 2) induced BL21-
CodonPlus(DE3)-RIL [pET29a arginine-rich peptide-tagged protein] cells; 3) cell lysate; 4) 4 μg of protein 
sample eluted from AR aptamer-based resin using ARGI buffer supplemented with GuHCl. The samples were 
denatured and separated on 12% SDS-PAGE followed by Coomassie brilliant blue staining. This is one of three 
independent experiments which is representative.
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Figure 10. The analysis of AR aptamer-based chromatography reproducibility. 5′-biotinylated AR aptamer 
bound to streptavidin-agarose resin was incubated with E. coli total protein extracts containing recombinant 
proteins. After washing, the bound protein was eluted using buffer supplemented with an appropriate GuHCl 
concentration. (A) R6, (B) R8 and (C) Tat49–57 tagged recombinant protein. Lanes: 1 and 2) GFP-tag, 3 and 4) 
tag-GST, 5 and 6) tag-PCNA. The purification of the tested protein was repeated nine times using the same 
resin. Next, 4 μg of protein sample eluted after the first and ninth purification cycle was denatured and separated 
on 12% SDS-PAGE followed by Coomassie staining. This is one of three independent experiments which is 
representative.
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Pull-down assay. 10 μL of 50% (w/v) HCSA resin was washed with water and AS1 buffer. Next it was incubated 
with 500 pmoles of the 5′-biotinylated Ref or 24–10 aptamer in 300 μL of AS1 buffer for 1 h at RT with gentle 
agitation. Next, the beads were washed (3 × 500 μL with AS1 buffer if not stated otherwise) and incubated with 
GFP, GST, PCNA fused with R6/R8/Tat49–57 or with proteins without any tag (final concentration 4 μM) in 500 μl 
of AS1 buffer at 4 °C for 1 h. The resin was then washed 5 × 500 μL with AS1 buffer to wash out unbound pro-
tein. The aptamer-bound protein was denatured with 1 × GLB buffer (50 mM Tris-HCl, 2% (w/v) SDS, 2% (w/v) 
bromophenol blue (w/v), 10% (v/v) glycerol, 200 mM β-mercaptoethanol, pH 6.8) at 95 °C for 5 min. Next, half 
of the protein sample volume was separated in 12% SDS-PAGE23, followed by Coomassie brilliant blue staining.
Determination of the 24–10 aptamer fragment essential for arginine-rich peptide tag binding. The exper-
iment was performed as described in section (Pull-down assay) with minor modifications. AS1 buffer 
was replaced with ARGI buffer (50 mM Tris-HCl, 300 mM NaCl, 5 mM EDTA, 0.01% (v/v) Tween 
20, pH 7.5). 20 μL of 50% (w/v) HCSA resin coupled with 1 nmole of the 5′-biotinylated full length 
24–10 aptamer (5 ′-CATGCTTCCCCAGGGAGATGGACGGCACGTCTTTGTAATTGGTTCTG 
AGTTCCGTTGTGGGAGGAACATGCGTCGCAAAC-3′) or its variants shortened either from the 5′ or 3′ end 
were incubated with R8-GST (final concentration 4 μM). After washing out the unbound protein 5 × 500 μL with 
ARGI buffer the aptamer-bound protein was denatured with 1 × GLB at 95 °C for 5 min. Next, one fortieth of the 
volume of each protein sample was separated on 12% SDS-PAGE followed by Coomassie brilliant blue staining.
Determination of protein elution conditions. The experiment was performed as described in section 
(Determination of the 24–10 aptamer fragment essential for arginine-rich peptide tag binding) with minor 
modifications. 20 μL of 50% (v/v) HCSA resin coupled with 1 nmole of the 5′-biotinylated AR aptamer 
(5′-CTTTGTAATTGGTTCTGAGTTCCGTTGTGGGAGGAACATG-3′) was incubated with the R6/R8 or 
Tat49–57-GST protein (final concentration 4 μM) in 500 μl of ARGI buffer. After washing out the unbound pro-
tein the bound protein was eluted with ARGI buffer (5 × 500 μL) supplemented with different concentrations of 
guanidine hydrochloride (GuHCl), in the following ranges: 0–600 mM for R6-GST, 0–700 mM for R8-GST and 
0–300 mM for Tat49–57-GST. The aptamer-bound protein was denatured with 1 × GLB at 95 °C for 5 min. Next, one 
fortieth of the volume of each protein sample was separated on 12% SDS-PAGE followed by Coomassie brilliant 
blue staining.
Purification of R6/R8/ Tat49–57-tagged proteins using the AR aptamer. The experiment was performed as described 
in section (Pull-down assay) with minor modifications. AS1 buffer was replaced with ARGI buffer. 14 nmoles of 
the 5′-biotinylated AR aptamer were immobilized using 150 μL of 50% (v/v) HCSA resin. After washing, the resin 
was incubated for 1 h with gentle agitation with 1 ml of E. coli total protein extract (final concentration 10 mg/mL) 
prepared similarly as described in section (Protein purification), in ARGI buffer. Unbound proteins were washed 
out with ARGI buffer, and the bound protein was eluted by rinsing the resin 5 × with ARGI buffer supplemented 
with appropriate concentrations of GuHCl. The eluted protein was concentrated using Amicon Ultra-0.5(Merck 
Millipore Ltd.) and dialyzed against S buffer without glycerol. The Bradford protein assay (Bio-Rad) was used to 
measure protein concentration in the samples which were next denaturated at 95 °C for 5 min and separated on 
12% SDS-PAGE, followed by Coomassie brilliant blue staining.
Reproducibility of AR aptamer-based chromatography. The experiment was performed as described in section 
(Purification of R6/R8/Tat49-57-tagged proteins using the AR aptamer) with minor modifications. After each 
purification procedure the HCSA-AR aptamer resin was regenerated with R buffer (50 mM Tris-HCl, 1 M NaCl, 
1 M GuHCl, 0.01% (v/v) Tween 20, pH 7.5). When not used the HCSA-AR aptamer resin was stored in S buffer 
at −80 °C.
Dissociation constant determination. The isothermal titration calorimetry experiments were carried 
out in duplicates at 25 °C using a VP-ITC instrument (MicroCal, Northampton, MA, USA). Typically, 30 injec-
tions of 4 µL aliquots of 200 µM AR aptamer were added into a 1.4355 ml calorimeter cell containing 20 µM tagged 
protein in 50 mM phosphate buffer (pH 7.6) containing 207 mM NaCl. The injection speed was 0.5 µL/s with 
4 min intervals between injections. All solutions were degassed under vacuum prior to use in ITC experiments. 
In order to ensure proper mixing after each injection, a constant stirring speed of 300 rpm was maintained during 
the experiment. The heat of the AR aptamer dilution was used to correct the total heat of binding prior to data 
analysis. The nonlinear analysis was performed according to the one set of sites model using Origin7 software.
Computational Analysis. The models of AR aptamer secondary structure and ΔG were calculated using 
the mfold web server18. The calculation was performed for the following conditions: temperature 25 °C and 
300 mM NaCl.
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